GlaxoSmithkline Pharmaceuticals Limited reported unaudited standalone earnings results for the second quarter and six months ended September 30, 2016. For the quarter, the company reported total income from operations of INR 7,991.2 million compared to INR 7,175.3 million a year ago. Profit from operations before other income and exceptional items was INR 1,341.6 million compared to INR 1,227.7 million a year ago. Profit from ordinary activities before tax was INR 1,524.0 million compared to INR 1,462.7 million a year ago. Net profit was INR 988.5 million or INR 11.7 per basic and diluted share compared to INR 955.5 million or INR 11.3 per basic and diluted share a year ago. For the six months, the company reported total income from operations of INR 15,044.5 million compared to INR 13,692.3 million a year ago. Profit from operations before other income and exceptional items was INR 2,191.4 million compared to INR 2,289.8 million a year ago. Profit from ordinary activities before tax was INR 2,632.2 million compared to INR 2,899.7 million a year ago. Net profit was INR 1,711.2 million or INR 20.2 per basic and diluted share compared to INR 1,895.6 million or INR 22.4 per basic and diluted share a year ago.